Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
Clinical trial NCT05373004 · UNKNOWN
Trial details
- NCT number
- NCT05373004
- Sponsor
- Omar Tarek Elfarargi
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-03-01
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.